Antidiuretic Agents: Antidiuretic agents are drugs or substances that reduce the formation and excretion of urine by increasing the reabsorption of water in the kidneys. They help the body retain water and maintain normal fluid balance.

Most antidiuretic agents act by mimicking or enhancing the action of antidiuretic hormone (ADH), also called vasopressin, on the kidneys. They are mainly used in conditions associated with excessive urine production (polyuria) and excessive thirst.
Classification of Antidiuretic Agents
Antidiuretic agents can be classified into the following groups:
1. Vasopressin and Its Analogues
These drugs mimic the action of antidiuretic hormone (ADH) and increase water reabsorption in the kidneys.
- Vasopressin
- Desmopressin
- Terlipressin
2. Drugs that Enhance ADH Action
These drugs enhance the antidiuretic effect of endogenous ADH and may help reduce urine formation.
- Chlorpropamide
- Carbamazepine
- Clofibrate
3. Drugs Used in Nephrogenic Diabetes Insipidus
These drugs reduce excessive urine output when the kidneys are less responsive to ADH.
- Thiazide diuretics – Hydrochlorothiazide
- Amiloride
- Indomethacin
Pharmacological Actions of Antidiuretic Agents
1. Vasopressin Analogs: Stimulate V1 receptors, leading to vasoconstriction and increased kidney water reabsorption.
2. Selective V2 Receptor Agonists: Specifically target the V2 receptors in the renal collecting ducts, promoting water reabsorption.
Dose of of Antidiuretic Agents
The dosage of antidiuretic agents depends on the specific medication and the condition being treated. It is crucial to follow the prescribed dose and frequency a healthcare professional recommends.
Indications of of Antidiuretic Agents
Antidiuretic agents are mainly used in conditions where excessive urine production or excessive loss of water occurs. Important indications include:
- Diabetes Insipidus – Used to reduce excessive urination and thirst caused by inadequate secretion or action of antidiuretic hormone (ADH).
- Nocturnal Enuresis (Bed-wetting) – Desmopressin is used to decrease nighttime urine production in selected patients.
- Nocturia – May be used to reduce excessive nighttime urine production in appropriate patients.
- Hemophilia A – Desmopressin can increase the release of factor VIII and von Willebrand factor, helping control bleeding in some patients.
- von Willebrand Disease – Desmopressin may be used to increase circulating von Willebrand factor and factor VIII in responsive patients.
- Excessive Urine Production after Certain Procedures – Antidiuretic therapy may be used in selected cases of excessive water loss under medical supervision.
Contraindications of Antidiuretic Agents
The contraindications vary depending on the specific antidiuretic drug. For desmopressin, the major contraindications include:
- Hyponatremia – Desmopressin can increase water retention and may further lower serum sodium levels.
- Moderate to Severe Renal Impairment – It is generally contraindicated when renal function is significantly reduced because the risk of water retention and hyponatremia increases.
- Polydipsia (Excessive Fluid Intake) – Excessive drinking during treatment increases the risk of water intoxication and hyponatremia.
- Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) – Use may worsen water retention and hyponatremia.
- Heart Failure or Significant Fluid Retention – Antidiuretic therapy may increase fluid retention and potentially worsen the condition.
- Uncontrolled Hypertension – Increased water retention may aggravate blood pressure in susceptible patients.
- Known Hypersensitivity – Patients with a known allergy to desmopressin or its components should not receive it.
- Conditions Requiring Fluid Restriction – Desmopressin should generally be avoided or used only under strict medical supervision when fluid retention could be harmful.
Important Precaution
The most important safety concern with antidiuretic therapy is water intoxication and hyponatremia. Therefore, fluid intake may need to be restricted and serum sodium monitored during treatment.
Editorial Note
This article has been carefully researched and written by Deepak Rajput with a focus on accuracy, clarity, and evidence-based healthcare information. Pharmaacademias.com




